13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-21, with 24 holding rows worth $221,515,000 by the sum of the rows.
- Accession
- 0000909012-15-000223
- Filer
- CIK 1493215
- Filed
- 2015-05-21
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2015
A holdings report, 24 entries on the cover page, a total value of $221,515,021,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $221,515,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
The cover page states a total of $221,515,021,000, about 1,000 times the sum of the rows, $221,515,000. The filer likely wrote its cover total in dollars and its rows in thousands. This page uses the sum of the rows.
Other managers
- included managerRTW MASTER FUND, LTD.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 355,395 | $37,110,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 1,585,098 | $26,558,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 990,981 | $23,813,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 375,623 | $21,666,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,261,361 | $20,420,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,064,247 | $19,476,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 2,410,000 | $16,304,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,622,633 | $15,999,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 100,000 | $12,077,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 2,665,643 | $7,917,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 71,315 | $3,001,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 204,000 | $2,701,000 | thousands by filing date | |
| PRESBIA PLC | G7234P100 | SHS | 350,000 | $2,587,000 | thousands by filing date | |
| AVALANCHE BIOT | 05337G107 | Common Stock | 51,300 | $2,079,000 | thousands by filing date | |
| REPROS THERAPEUTICS INC | 76028H209 | COM | 229,364 | $1,970,000 | thousands by filing date | |
| CORONADO BIOSCIENCES INC | 21976U109 | COM | 500,000 | $1,925,000 | thousands by filing date | |
| CYTRX CORP | 232828509 | COM PAR $.001 | 563,814 | $1,900,000 | thousands by filing date | |
| LIPOCINE INC NEW | 53630X104 | CMN | 209,333 | $1,444,000 | thousands by filing date | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 8,721 | $1,230,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 31,872 | $1,150,000 | thousands by filing date | |
| LPATH INC-CLASS A | 548910306 | CMN | 60,000 | $148,000 | thousands by filing date | |
| SHAKE SHACK INC | 819047101 | CL A | 500 | $25,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 2,400 | $8,000 | thousands by filing date | |
| Berkshire Hathaway Inc | 084670702 | COM | 50 | $7,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000909012-15-000223 | this filing | 2015-05-21 | acceptance time not in the bulk data set |